Trial intelligence / Profile preview

Acceptability of GONAL-f Prefilled Pen for Ovarian Stimulation

NCT01183143Phase 3Completed

Sponsor
Merck KGaA
Start
May 2004
Primary completion
Mar 2006
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of follitropin alfa in infertility, sponsored by Merck KGaA. Started May 2004; status: completed.

02

Drugs

follitropin alfa
03

Conditions

infertility

Beyond the preview

Go deeper on NCT01183143.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01183143.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call